DLB
Dolby Laboratories, Inc.
$49.99
+0.84 (+1.71%)
At close · Jul 16
Market Cap
$4.73B
Shares
94,598,115
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Kevin Yeaman | CEO | $10,193,397 |
| John Couling | Senior Vice President, Entertainment | $4,130,882 |
| Andy Sherman | General Counsel | $4,044,164 |
| Shriram Revankar | Senior Vice President, Advanced Technology Group | $3,688,289 |
| Robert Park | CFO | $3,620,627 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Kevin Yeaman | CEO | $9,678,964 |
| John Couling | Senior Vice President, Entertainment | $3,847,523 |
| Andy Sherman | General Counsel | $3,756,577 |
| Shriram Revankar | Senior Vice President, Advanced Technology Group | $3,625,715 |
| Robert Park | CFO | $3,348,158 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Kevin Yeaman | CEO | $9,504,201 |
| John Couling | Senior Vice President, Entertainment | $3,896,127 |
| Andy Sherman | General Counsel | $3,509,190 |
| Robert Park | CFO | $3,291,806 |
| Todd Pendleton | Senior Vice President, Chief Marketing Officer | $3,188,239 |
| Shriram Revankar | Senior Vice President, Advanced Technology Group | $2,360,974 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Kevin Yeaman | CEO | $9,407,217 |
| Shriram Revankar | Senior Vice President, Advanced Technology Group | $5,449,178 |
| Robert Park | CFO | $4,948,662 |
| John Couling | Senior Vice President, Entertainment | $3,847,629 |
| Andy Sherman | General Counsel | $3,440,169 |
| Todd Pendleton | Senior Vice President, Chief Marketing Officer | $3,106,026 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Kevin Yeaman | CEO | $9,629,118 |
| Andy Sherman | General Counsel | $3,527,315 |
| Todd Pendleton | Senior Vice President, Chief Marketing Officer | $3,225,122 |
Key facts
CIK
1308547
CUSIP
25659T107
13F (30d)
35 filings
34 filers
Visit website
Investor relations